Intravitreal bevacizumab - Author reply

被引：19
作者：
Avery, Robert L.
Pieramici, Dante J.
Rabena, Melvin D.
Castellarin, Alessandro A.
Nasir, Ma'an A.
Giust, Matthew J.
机构：
来源：
OPHTHALMOLOGY | 2007年 / 114卷 / 02期
关键词：
D O I：
10.1016/j.ophtha.2006.10.001
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：400 / 401
页数：2
相关论文
共 3 条
[1]   Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy [J].
Avery, Robert L. ;
Pearlman, Joel ;
Pieramici, Dante J. ;
Rabena, Melvin D. ;
Castellarin, Alessandro A. ;
Nasir, Ma'an A. ;
Giust, Matthew J. ;
Wendel, Robert ;
Patel, Arun .
OPHTHALMOLOGY, 2006, 113 (10) :1695-1705
[2]   Six-month stability of bevacizumab (avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing [J].
Bakri, Sophie J. ;
Snyder, Melissa R. ;
Pulido, Jose S. ;
McCannel, Colin A. ;
Weiss, William T. ;
Singh, Ravinder J. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (05) :519-522
[3]  
PULIDO JS, IN PRESS EYE
1